Effects of rosiglitazone on renal TGF-β and collagen-IV of diabetic rats
Wei Li
Abstract
Wei Li
Abstract
Objective To investigate the effects of rosiglitazone on renal TGF-β and collagen-Ⅳ in diabetic rats.Methods Forty rats were randomized into 3 groups of normal control rats(group C),diabetic rats(group DC)and diabetic rats treated with rosiglitazone(group DR).After 10 weeks,blood glucose and microalbuminuria were measured and pathologic change of the kidney was observed.TGF-β and collagen-Ⅳ expressions in kidneny cortex were observed by immunohistochemistry.Results Kidney index,microalbuminuria and the expressions of TGF-β and collagen-Ⅳ in group DC were significantly higher than those in group C and group DR(P0.01).Conclusion Rosiglitazone has a protective effect on the kidney in diabetic rats through downregulating the expression of TGF-β and collagen-Ⅳ.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effects of rosiglitazone on renal TGF-β and collagen-Ⅳ in diabetic rats.Methods Forty rats were randomized into 3 groups of normal control rats(group C),diabetic rats(group DC)and diabetic rats treated with rosiglitazone(group DR).After 10 weeks,blood glucose and microalbuminuria were measured and pathologic change of the kidney was observed.TGF-β and collagen-Ⅳ expressions in kidneny cortex were observed by immunohistochemistry.Results Kidney index,microalbuminuria and the expressions of TGF-β and collagen-Ⅳ in group DC were significantly higher than those in group C and group DR(P0.01).Conclusion Rosiglitazone has a protective effect on the kidney in diabetic rats through downregulating the expression of TGF-β and collagen-Ⅳ.
Key concepts: Rosiglitazone, Medicine, Internal medicine, Endocrinology, Microalbuminuria, Kidney, Transforming growth factor, Diabetic nephropathy